Cambridge, United Kingdom

Chris Rossant

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chris Rossant: Innovator in Therapeutic Molecules

Introduction

Chris Rossant is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic molecules, particularly in the treatment of cancer. With a total of three patents to his name, Rossant's work focuses on innovative binding molecules that target specific antigens.

Latest Patents

Among his latest patents, Rossant has developed binding molecules that specifically bind to prostate-specific membrane antigen (PSMA). These inventions include single human variable heavy chain domain antibodies and related methods for cancer treatment. His research aims to enhance the efficacy of cancer therapies through targeted approaches.

Career Highlights

Chris Rossant is currently associated with Crescendo Biologics Limited, where he continues to advance his research in therapeutic molecules. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.

Collaborations

Some of his notable coworkers include Brian Timothy McGuinness and Thomas Sandal, who contribute to the innovative environment at Crescendo Biologics Limited.

Conclusion

Chris Rossant's contributions to the field of therapeutic molecules exemplify the importance of innovation in cancer treatment. His patents and ongoing research hold promise for improving therapeutic strategies and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…